Clinical Trials for Chronic Hepatitis B

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

• Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
• Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
• Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
• Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Chronic Hepatitis B is grouped into the following categories:-

• View by trial name
• View by drugs used in Chronic Hepatitis B clinical trials

Clinical Trials by trial name

The format for each of the following is:

• The name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.
• followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Chronic Hepatitis B:

• Open-Label Treatment Extension Study for Patients Who Complete Study RNA200103-201 - This study is no longer recruiting patients (Current: 23 Nov 2006) - pradefovir mesylate,adefovir dipivoxyl
• Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - pradefovir mesylate,adefovir dipivoxyl
• Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Entecavir
• Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection - This study has been completed (Current: 23 Nov 2006) - ACH-126, 443 (beta-L-Fd4C)
• An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options - This study has been completed (Current: 23 Nov 2006) - Adefovir Dipivoxil
• Lamivudine for Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006) - Lamivudine
• Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) - This study has been completed (Current: 23 Nov 2006) - Lamivudine plus Polyethylene glyco-interferon alfa-2b,Lamivudine
• Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a - This study is currently recruiting patients (Current: 23 Nov 2006)
• Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - pegylated interferon alfa-2a,tenofovir DF / emtricitabine combination therapy,pegIFN / TDF / FTC combination therapy
• Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment - This study is currently recruiting patients (Current: 23 Nov 2006) - Pegylated Interferon-alfa-2a
• Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pegylated Interferon,Lamivudine
• Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006) - adefovir dipivoxil tablets
• Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) - This study has been completed (Current: 23 Nov 2006) - Lamivudine/ Placebo 100mg daily
• Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis - This study is currently recruiting patients (Current: 23 Nov 2006) - adefovir dipivoxil
• Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta - This study is currently recruiting patients (Current: 23 Nov 2006) - pegylated IFN alfa-2b plus ribavirin
• Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006) - pegylated interferon, thymosin alpha (drug)
• Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-Resistant Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - ACH126, 433 (b-L-Fd4C)
• Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. - This study is no longer recruiting patients (Current: 23 Nov 2006) - ACH-126, 443 (beta-L-Fd4C)
• Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis - This study is currently recruiting patients (Current: 23 Nov 2006) - Telbivudine (LdT) versus Lamivudine
• Safety and Acceptability of a Vaginal Microbicide - This study is currently recruiting patients (Current: 23 Nov 2006) - 1% tenofovir gel
• Long-Term Lamivudine Therapy for Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006)
• KRN7000 in Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006) - KRN7000
• Peg-Intron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498) - This study is currently recruiting patients (Current: 23 Nov 2006) - pegylated interferon alpha-2b,adefovir dipivoxil
• Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection - This study has been completed (Current: 23 Nov 2006) - Adefovir Dipivoxil
• A Phase III Study of Entecavir Vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen - This study has been completed (Current: 23 Nov 2006) - Entecavir
• A Phase III Study of Entecavir Vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen - This study has been completed (Current: 23 Nov 2006) - Entecavir
• A Phase III Study of Entecavir Vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine - This study has been completed (Current: 23 Nov 2006) - Entecavir
• Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006) - PEGASYS
• A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - telbivudine or lamivudine
• Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adefovir Dipivoxil for oral suspension, 2 mg/mL
• Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adefovir Dipivoxil, 10 mg tablet or oral suspension, 2 mg/mL
• Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - Telbivudine (LdT),Adefovir Dipivoxil
• A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - tenofovir disoproxil fumarate 300 mg once daily,adefovir dipivoxil 10 mg once daily
• A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - tenofovir disoproxil fumarate 300 mg once daily,adefovir dipivoxil 10 mg once daily
• Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006) - telbivudine,lamivudine
• Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006) - Lamivudine,Telbivudine
• Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies - This study is currently recruiting patients (Current: 23 Nov 2006) - telbivudine
• Long Term Follow-Up of Pegylated-Interferon Alpha-2b - This study is currently recruiting patients (Current: 23 Nov 2006)
• 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV - This study is currently recruiting patients (Current: 23 Nov 2006) - 4-Methylumbelliferone (Heparvit®)
• Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006) - interferon alpha 2b plus ribavirin,interferon alpha 2b plus placebo
• Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. - This study is currently recruiting patients (Current: 23 Nov 2006) - tenofovir disoproxil fumarate,emtricitabine / tenofovir disoproxil fumarate,entecavir
• Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006) - Adefovir Dipivoxil
• Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - tenofovir DF 300 mg once daily,emtricitabine 200 mg/tenofovir DF 300 mg once daily
• Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - adefovir dipivoxil
• A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone - This study is no longer recruiting patients (Current: 23 Nov 2006) - LAMIVUDINE
• A Study in Korea of the Antiviral Activity and Safety of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection Who Are Negative For Hepatitis B e Antigen - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - entecavir,lamivudine
• A Phase 4 Study of Entecavir in Patients With Chronic HBV Infection - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - entecavir,other standard of care HBV nucleoside/nucleotide analogue
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C - This study is currently recruiting patients (Current: 23 Nov 2006) - Peginterferon Alfa-2a plus Ribavirin
• Lamivudine and Adefovir to Treat Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006) - Adefovir Dipivoxil
• Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection. - This study has been terminated (Current: 23 Nov 2006) - Hepsera
• Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Hepsera
• Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection - This study is no longer recruiting patients (Current: 23 Nov 2006) - entecavir,adefovir

Drugs used in Clinical Trials for Chronic Hepatitis B

The format for each of the following is:

• The drug,
• followed by the name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Chronic Hepatitis B:

• 1% tenofovir gel - Safety and Acceptability of a Vaginal Microbicide - This study is currently recruiting patients (Current: 23 Nov 2006)
• 4-Methylumbelliferone (Heparvit®) - 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV - This study is currently recruiting patients (Current: 23 Nov 2006)
• ACH-126, 443 (beta-L-Fd4C) - Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection - This study has been completed (Current: 23 Nov 2006)
• ACH-126, 443 (beta-L-Fd4C) - Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ACH126, 433 (b-L-Fd4C) - Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-Resistant Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil 10 Mg Once Daily - A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil 10 Mg Once Daily - A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil Tablets - Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil for oral suspension, 2 mg/mL - Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil, 10 mg tablet or oral suspension, 2 mg/mL - Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil - Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil - Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil - An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options - This study has been completed (Current: 23 Nov 2006)
• Adefovir Dipivoxil - Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection - This study has been completed (Current: 23 Nov 2006)
• Adefovir Dipivoxil - Lamivudine and Adefovir to Treat Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil - Peg-Intron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil - Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxil - Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxyl - Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir Dipivoxyl - Open-Label Treatment Extension Study for Patients Who Complete Study RNA200103-201 - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adefovir - Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Emtricitabine / Tenofovir Disoproxil Fumarate - Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Emtricitabine 200 Mg/Tenofovir Df 300 Mg Once Daily - Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Entecavir - A Phase 4 Study of Entecavir in Patients With Chronic HBV Infection - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Entecavir - A Phase III Study of Entecavir Vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen - This study has been completed (Current: 23 Nov 2006)
• Entecavir - A Phase III Study of Entecavir Vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen - This study has been completed (Current: 23 Nov 2006)
• Entecavir - A Phase III Study of Entecavir Vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine - This study has been completed (Current: 23 Nov 2006)
• Entecavir - A Study in Korea of the Antiviral Activity and Safety of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection Who Are Negative For Hepatitis B e Antigen - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Entecavir - Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Entecavir - Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Entecavir - Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Hepsera - Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection. - This study has been terminated (Current: 23 Nov 2006)
• Hepsera - Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Interferon Alpha 2B Plus Placebo - Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006)
• Interferon Alpha 2B Plus Ribavirin - Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006)
• KRN7000 - KRN7000 in Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006)
• LAMIVUDINE - A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lamivudine plus Polyethylene glyco-interferon alfa-2b - Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) - This study has been completed (Current: 23 Nov 2006)
• Lamivudine/ Placebo 100mg daily - Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) - This study has been completed (Current: 23 Nov 2006)
• Lamivudine - A Study in Korea of the Antiviral Activity and Safety of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection Who Are Negative For Hepatitis B e Antigen - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Lamivudine - Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lamivudine - Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) - This study has been completed (Current: 23 Nov 2006)
• Lamivudine - Lamivudine for Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006)
• Lamivudine - Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lamivudine - Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Other Standard Of Care Hbv Nucleoside/Nucleotide Analogue - A Phase 4 Study of Entecavir in Patients With Chronic HBV Infection - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• PEGASYS - Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B - This study has been completed (Current: 23 Nov 2006)
• Pegifn / Tdf / Ftc Combination Therapy - Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Peginterferon Alfa-2a plus Ribavirin - Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pegylated Ifn Alfa-2B Plus Ribavirin - Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pegylated Interferon Alfa-2A - Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pegylated Interferon Alpha-2B - Peg-Intron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pegylated Interferon, Thymosin Alpha (Drug) - Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pegylated Interferon-alfa-2a - Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pegylated Interferon - Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pradefovir Mesylate - Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pradefovir Mesylate - Open-Label Treatment Extension Study for Patients Who Complete Study RNA200103-201 - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Telbivudine (LdT) versus Lamivudine - Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Telbivudine (LdT) - Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Telbivudine Or Lamivudine - A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Telbivudine - Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B - This study is currently recruiting patients (Current: 23 Nov 2006)
• Telbivudine - Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Telbivudine - Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies - This study is currently recruiting patients (Current: 23 Nov 2006)
• Tenofovir Df / Emtricitabine Combination Therapy - Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Tenofovir Df 300 Mg Once Daily - Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Tenofovir Disoproxil Fumarate 300 Mg Once Daily - A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Tenofovir Disoproxil Fumarate 300 Mg Once Daily - A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Tenofovir Disoproxil Fumarate - Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. - This study is currently recruiting patients (Current: 23 Nov 2006)

The trial data on this page has been sourced from

• The U.S. National Library of Medicine (NLM) together with ClinicalTrials.gov

 » Next page: Images relating to Chronic Hepatitis B

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• Images relating to Chronic Hepatitis B
• HEPATOMEGALY (Algorithmic Diagnosis of Symptoms and Signs)
• JAUNDICE (Algorithmic Diagnosis of Symptoms and Signs)
• Hepatomegaly (In a Page: Signs and Symptoms)
• Jaundice (In a Page: Signs and Symptoms)

Tools & Services:

• Bookmark this page
• Take a survey relating to Chronic Hepatitis B
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com

Common Health Mistakes

Symptom
Checker

Search Specialists by State and City